Health Highlights: Oct. 1, 2021

Merck to seek emergency approval for its new COVID antiviral pill: In a trial of the drug molnupiravir, the risk of hospitalization and death was halved when given to high-risk patients within five days of infection. Read more
Has the pandemic made the opioid epidemic worse? In interviews with HealthDay Now, experts say that overdoses soared, but the rise of telehealth also helped many get vital treatments. Read more
A silver lining to the pandemic: less vaping among teens. New statistics show a 40% drop in use, as teens had to stay home more during lockdowns and closures. Read more
New data shows police killings underreported: And Black Americans were 3.5 times more likely to die from police violence than white Americans, the study found. Read more
Related Posts
Molnupiravir Does Not Reduce COVID-19-Related Hospitalization, Death
THURSDAY, Dec. 29, 2022 (HealthDay News) -- For high-risk vaccinated adults,...
Unos expertos en el sueño advierten que no se debe dar melatonina a los niños
MIÉRCOLES, 28 de septiembre de 2022 (HealthDay News) -- El uso de la melatonina,...
AHA News: Upping Your Step Count, Even in Small Amounts, May Increase Life Span
THURSDAY, Nov. 3, 2022 (American Heart Association News) -- Adding 1,000 or even...
Living in Disadvantaged Neighborhood Shortens Breast Cancer Survival
THURSDAY, April 27, 2023 (HealthDay News) -- Breast cancer-specific survival is...